Related references
Note: Only part of the references are listed.Rho-kinase phosphorylates eNOS at threonine 495 in endothelial cells
Masayuki Sugimoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
A postmarketing surveillance study of fasudil treatment after aneurysmal subarachnoid hemorrhage
Yoshio Suzuki et al.
SURGICAL NEUROLOGY (2007)
Myocardin-related transcription factors - Critical coactivators regulating cardiovascular development and adaptation
Michael S. Parmacek
CIRCULATION RESEARCH (2007)
Anti-ischemic effects of fasudil, a specific Rho-kinase inhibitor, in patients with stable effort angina
Yoshihiro Fukumoto et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2007)
Rho kinase in the regulation of cell death and survival
Jianjian Shi et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2007)
A Rho-kinase inhibitor, fasudil, prevents development of diabetes and nephropathy in insulin-resistant diabetic rats
Yuichi Kikuchi et al.
JOURNAL OF ENDOCRINOLOGY (2007)
Vasodilatory effect of subsequent administration of fasudil, a Rho-kinase inhibitor, surpasses that of nitroglycerin at the concentric coronary stenosis in patients with stable angina pectoris
T Otsuka et al.
CIRCULATION JOURNAL (2006)
Involvement of rho kinase in the ouabain-induced contractions of the rat renal arteries
M Ark et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Targeting Rho and Rho-kinase in the treatment of cardiovascular disease
K Budzyn et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Rho/Rho kinase as a potential target for the treatment of renal disease
S Wakino et al.
DRUG NEWS & PERSPECTIVES (2005)
Efficacy and safety of fasudil in patients with stable angina - A double-blind, placebo-controlled, phase 2 trial
RM Vicari et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Effects of fasudil in acute ischemic stroke: Results of a prospective placebo-controlled double-blind trial
M Shibuya et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
Rho-kinase inhibitors show promise in pulmonary hypertension
SA Doggrell
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2005)
Rho kinase as potential therapeutic target for cardiovascular diseases: opportunities and challenges
E Hu et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2005)
LIM kinase 1 coordinates microtubule stability and actin polymerization in human endothelial cells
M Gorovoy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Rho-kinase inhibitor improves increased vascular resistance and impaired vasodilation of the forearm in patients with heart failure
T Kishi et al.
CIRCULATION (2005)
Rho kinase, a promising drug target for neurological disorders
BK Mueller et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Inhibition of Rho-kinase stimulates nitric oxide-independent vasorelaxation
M Löhn et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Rho-kinase is an important therapeutic target in cardiovascular medicine
H Shimokawa et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Rho-kinase, a potential therapeutic target for the treatment of hypertension
Y Hirooka et al.
DRUG NEWS & PERSPECTIVES (2004)
Two simple and generic antibody-independent kinase assays: Comparison of a bioluminescent and a microfluidic assay format
A Pommereau et al.
JOURNAL OF BIOMOLECULAR SCREENING (2004)
Novel role of microtubules in thrombin-induced endothelial barrier dysfunction
AA Birukova et al.
FASEB JOURNAL (2004)
Rho signaling in vascular diseases
TM Seasholtz et al.
MOLECULAR INTERVENTIONS (2004)
RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: A mechanism for diabetes-associated erectile dysfunction
TJ Bivalacqua et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The role of Rho kinase and extracellular regulated kinase-mitogen-activated protein kinase in α2-adrenoceptor-mediated vasoconstriction in the porcine palmar lateral vein
RE Roberts
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Protein kinase a in complex with rho-kinase inhibitors Y-27632, fasudil, and H-1152P: Structural basis of selectivity
C Breitenlechner et al.
STRUCTURE (2003)
Mechanisms of plaque vulnerability and rupture
PK Shah
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells
XF Ming et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Kinetic mechanism for human Rho-Kinase II (ROCK-II)
JW Trauger et al.
BIOCHEMISTRY (2002)
Periadventitial fat releases a vascular relaxing factor
M Löhn et al.
FASEB JOURNAL (2002)
Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases
H Shimokawa
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2002)
Regulation and functions of Rho-associated kinase
M Amano et al.
EXPERIMENTAL CELL RESEARCH (2000)
Share Paper
